GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Novacyt SA (XPAR:ALNOV) » Definitions » Price-to-Tangible-Book

Novacyt (XPAR:ALNOV) Price-to-Tangible-Book : 0.48 (As of May. 07, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Novacyt Price-to-Tangible-Book?

As of today (2024-05-07), Novacyt's share price is €0.771. Novacyt's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was €1.62. Hence, Novacyt's Price to Tangible Book Ratio of today is 0.48.

The historical rank and industry rank for Novacyt's Price-to-Tangible-Book or its related term are showing as below:

XPAR:ALNOV' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.26   Med: 4.93   Max: 239
Current: 0.48

During the past 12 years, Novacyt's highest Price to Tangible Book Ratio was 239.00. The lowest was 0.26. And the median was 4.93.

XPAR:ALNOV's Price-to-Tangible-Book is ranked better than
95.42% of 698 companies
in the Medical Devices & Instruments industry
Industry Median: 2.75 vs XPAR:ALNOV: 0.48

A closely related ratio is called PB Ratio. As of today, Novacyt's share price is €0.771. Novacyt's Book Value per Sharefor the quarter that ended in Jun. 2023 was €1.77. Hence, Novacyt's P/B Ratio of today is 0.44.


Novacyt Price-to-Tangible-Book Historical Data

The historical data trend for Novacyt's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novacyt Price-to-Tangible-Book Chart

Novacyt Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 4.87 2.08 0.72

Novacyt Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.97 2.08 0.96 0.72 0.26

Competitive Comparison of Novacyt's Price-to-Tangible-Book

For the Medical Devices subindustry, Novacyt's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novacyt's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Novacyt's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Novacyt's Price-to-Tangible-Book falls into.



Novacyt Price-to-Tangible-Book Calculation

Novacyt's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2023 )
=0.771/1.62
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Novacyt Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Novacyt's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Novacyt (XPAR:ALNOV) Business Description

Traded in Other Exchanges
Address
13, Avenue Morane Saulnier, Velizy-Villacoublay, FRA, 78140
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment.

Novacyt (XPAR:ALNOV) Headlines

No Headlines